Notes from members of ProjectAccept.org’s advisory council Vaccine Strategy: David Knipe is working with Sanofi on an HSV-2 vaccine; it’s a live, attenuated strain (deleted in a number of genes). Right now, he showed protection from primary infection in mice, and he’s answering a question right now about it being much […]
